Briacell Therapeutics Corp (BCTX) — Capital Reinvestment Ratio

Latest as of October 2012: 116.81x

Briacell Therapeutics Corp (BCTX) has a Capital Reinvestment Ratio of 116.81x as of October 2012, meaning it reinvests 117% of its operating cash flow ($3.96K) in capital expenditures ($462.21K). See Briacell Therapeutics Corp balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

116.81x
Capex / Operating Cash Flow

Operating Cash Flow

$3.96K
USD

Capital Expenditures

$462.21K
USD

Data as of

Oct 2012
Most recent filing

Annual Capital Reinvestment Ratio for Briacell Therapeutics Corp (None–None)

Year-by-year Capital Reinvestment Ratio for Briacell Therapeutics Corp from None to None. For live market cap and broader valuation context, see Briacell Therapeutics Corp (BCTX) market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow